(Q38021672)

27 August 2017

title

Heartache and heartbreak--the link between depression and cardiovascular disease (English)

1 reference

27 August 2017

main subject

cardiovascular disease

1 reference

Pascal J Goldschmidt-Clermont

inferred from title

author

series ordinal

2

object named as

Pascal J Goldschmidt-Clermont

1 reference

27 August 2017

Charles B Nemeroff

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

26 June 2012

1 reference

Nature Reviews Cardiology

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

9

1 reference

27 August 2017

page(s)

526-539

1 reference

A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Probit structural equation regression model: general depressive symptoms predicted post-myocardial infarction mortality after controlling for somatic symptoms of depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Mental depression and cardiovascular disease: a multifaceted, bidirectional association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Lifetime risks of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982-1991. Established Populations for the Epidemiologic Studies of the Elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressive symptoms and health-related quality of life: the Heart and Soul Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the Heart and Soul Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and vulnerability to incident physical illness across 10 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression is a risk factor for coronary artery disease in men: the precursors study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Hospitalization for depression is associated with an increased risk for myocardial infarction not explained by lifestyle, lipids, coagulation, and inflammation: the SHEEP Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Quantifying links between acute myocardial infarction and depression, anxiety and schizophrenia using case register databases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and all-cause and coronary heart disease mortality among adults with and without diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Combined effects of depressive symptoms and resting heart rate on mortality: the Whitehall II prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression after coronary artery disease is associated with heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Relationship of depressive symptoms with hospitalization and death in Japanese patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressive symptoms and outcomes in patients with heart failure: data from the COACH study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression following myocardial infarction. Impact on 6-month survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

The role of depression and anxiety symptoms in hospital readmissions after cardiac surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Clinical depression, posttraumatic stress disorder, and comorbid depression and posttraumatic stress disorder as risk factors for in-hospital mortality after coronary artery bypass grafting surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Predictive relationship between depression and physical functioning after coronary surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Differential Associations Between Specific Depressive Symptoms and Cardiovascular Prognosis in Patients With Stable Coronary Heart Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Anhedonia as predictor of clinical events after acute coronary syndromes: a 3-year prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Mental disorders and use of cardiovascular procedures after myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Obesity, inflammation, and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Inflammatory mechanisms in major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Isolation of putative progenitor endothelial cells for angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressive symptoms and levels of C-reactive protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and C-reactive protein: population-based Health 2000 Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Relationship between depression and C-reactive protein in a screening population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association of high-sensitivity C-reactive protein with de novo major depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressive symptoms and inflammation among heart failure patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association between depression and inflammation--differences by race and sex: the META-Health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Atherosclerosis — An Inflammatory Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Inflammation in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Platelets and coronary heart disease: potential psychophysiologic mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Exaggerated platelet reactivity in major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Platelet reactivity in depressed patients treated with paroxetine: preliminary findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

The association of depression with platelet activation: evidence for a treatment effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Platelet function in patients with depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and platelet activation in outpatients with stable coronary heart disease: findings from the Heart and Soul Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Persistent versus transient depressive symptoms in relation to platelet hyperactivation: a longitudinal analysis of dementia caregivers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Abnormal platelet aggregation associated with fluoxetine therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Symptoms of depression and impaired endothelial function in healthy adolescent women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association between clinical depression and endothelial function measured by forearm hyperemic reactivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Coronary endothelial dysfunction associated with a depressive mood in patients with atypical angina but angiographically normal coronary artery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressed mood and flow-mediated dilation: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression and oxidative damage to lipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression predicts elevated endothelin-1 in patients with coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Atherosclerosis 2005: recent discoveries and novel hypotheses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Endothelial progenitor cells in cardiovascular disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Molecular evidence for arterial repair in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Aging, progenitor cell exhaustion, and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

An essential role for diet in exercise-mediated protection against dyslipidemia, inflammation and atherosclerosis in ApoE⁻/⁻ mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Role of endothelial progenitor cells in the beneficial effects of physical exercise on atherosclerosis and coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Habitual exercise and arterial aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Statins and the endothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Circulating endothelial cells and endothelial progenitor cells in obstructive sleep apnea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Relationships between vascular dysfunction, circulating endothelial progenitor cells, and psychological status in healthy subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association of depression with reduced heart rate variability in coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Subclinical hypothyroidism and the risk of coronary heart disease and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Antithyroid antibodies in depressed patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Urinary Cortisol and Six-Year Risk of All-Cause and Cardiovascular Mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Associations between the cortisol awakening response and heart rate variability.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Early identification of cardiovascular risk using genomics and proteomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Epigenetics and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

The Association Between Depression and Heart Disease: The Role of Genetic Factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Genetic predictors of depressive symptoms in cardiac patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Shared genetic factors in the co-occurrence of symptoms of depression and cardiovascular risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Common genes contribute to depressive symptoms and heart rate variability: the Twins Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depressive symptoms and heart rate variability: evidence for a shared genetic substrate in a study of twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Epigenetic modifications and human pathologies: cancer and CVD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

DNA methylation and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Epigenetic regulation of the neural transcriptome: the meaning of the marks.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Epigenomics reveals a functional genome anatomy and a new approach to common disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Insights into causal pathways for ischemic heart disease: adverse childhood experiences study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Evolution in health and medicine Sackler colloquium: Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Of cardiovascular illness and diversity of biological response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Early identification of atherosclerotic disease by noninvasive imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Early detection of myocardial dysfunction and heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Persistent cognitive depressive symptoms are associated with coronary artery calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Association between depression and intima-media thickness of carotid bulb in asymptomatic young adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Vascular function in older adults with depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Depression screening and patient outcomes in cardiovascular care: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Use of specific serotonin reuptake inhibitors (SSRIs) (Sertraline or Citalopram) in the treatment of depression reduces the cardiovascular risk in the elderly: evidence from a Sicilian population >80 years recovered in the assisted sanitary residenc

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Does improving mood in depressed patients alter factors that may affect cardiovascular disease risk?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.91

Coronary artery disease in association with depression or anxiety among patients undergoing angiography to investigate chest pain.

31 March 2020

1 reference

12 December 2020

Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets

1 reference

12 December 2020

On the Memory of a Chronic Illness

1 reference

12 December 2020

Inflammation, stem cells and atherosclerosis genetics.

1 reference

12 December 2020

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

1 reference

12 December 2020

Linear and nonlinear heart rate dynamics in elderly inpatients. Relations with comorbidity and depression.

1 reference

12 December 2020

Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly).

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2012.91

1 reference

27 August 2017

1 reference